Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in the United States:
sales of $8.54 billion
of which 84%
was CSL Behring),
Daiichi Sankyo Company Limited
of which 93%
was Prescription drugs), and
Eisai Company Limited
of which 88%
was Pharmaceutical Business).
Takeda Pharmaceutical Company Limited reported sales of $18.90 billion
March of 2019.
increase of 18.1%
versus 2018, when the company's sales were $16.01 billion.
Sales of Pharmaceutical Business saw an increase
19.2% in 2019, from
$15.31 billion to $18.26 billion.
Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2019:
sales of Intellectual Property and Service Revenu fell 7.8% to $639.27 million.
(However, this segment's sales were only a very small portion of the company's overall sales).